Top Story

Stool volatile organic compounds identified patients with C. difficile-associated diarrhea

September 19, 2014

WASHINGTON, D.C. — Stool volatile organic compound analysis differentiated between patients with and without Clostridium difficile-associated diarrhea, according to data presented at ICAAC 2014.

Currently there is “a delay of 3-5 days between the onset of symptoms and diagnosis of C. diff,” because of delays in ordering the stool sample, waiting for the patient to produce the stool sample, and turnaround time once it reaches the microbiology lab, Sophia Koo, MD, of the Brigham and Women’s Hospital and Harvard Medical School, told Healio.com/Gastroenterology. “A lot of the transmission might happen during that period of time between the onset of symptoms and diagnosis, so the idea was to develop a way to assess the volatile metabolome of the microbiome of people with toxigenic C. diff infection.”

Patent filed for injectable HBV, liver cancer drug in China

September 18, 2014
Biostar Pharmaceuticals has filed an invention and creation patent application in China for oleanolic acid injection for the treatment of hepatitis B virus infection and…
In the Journals

Half of patients with HIV not screened regularly for HCV

September 17, 2014
Researchers from Boston Medical Center have found that although most patients with HIV were screened for hepatitis C virus infection when enrolling into care, only half…
figure In the Journals

HAV in the Middle East and North Africa (MENA) region declined in younger populations

September 17, 2014
Seroprevalence trends in hepatitis A virus infection indicated a decline among younger populations in the Middle East and North Africa region, while areas with less…
CME
figure

HCV Consults: Volume 1, Number 2

This activity is supported by educational grants from AbbVie and Genentech.

Approved interferon-free therapy has already become entrenched among clinicians for patients with HCV genotypes 2 and…
More »
Meeting News Coverage Video
figure

High SVR rates met among HCV patients in ION-2

May 15, 2014
CHICAGO — HCV Next Editorial Board member Paul Y. Kwo, MD, professor of medicine and director of…
More »
CME
figure

In the Pink! A Closer Look at Pediatric Conjunctivitis

This activity is supported by an educational grant from Alcon.

Bacterial conjunctivitis is the most common conjunctivitis in infants and preschool-aged children. Pediatricians must…
More »

Filter By:

figure Meeting News Coverage

Stool volatile organic compounds identified patients with C. difficile-associated diarrhea

September 19, 2014
WASHINGTON, D.C. — Stool volatile organic compound analysis differentiated between patients with and without Clostridium difficile-associated…

Patent filed for injectable HBV, liver cancer drug in China

September 18, 2014
Biostar Pharmaceuticals has filed an invention and creation patent application in China for oleanolic acid injection for the treatment of hepatitis B…
In the Journals

Half of patients with HIV not screened regularly for HCV

September 17, 2014
Researchers from Boston Medical Center have found that although most patients with HIV were screened for hepatitis C virus infection when enrolling…
figure In the Journals

HAV in the Middle East and North Africa (MENA) region declined in younger populations

September 17, 2014
Seroprevalence trends in hepatitis A virus infection indicated a decline among younger populations in the Middle East and North Africa region, while…
Meeting News Coverage

Endoscopic abnormalities not correlated with presence, absence of scrub typhus-related GI symptoms

September 11, 2014
WASHINGTON, D.C. — The presence or absence of scrub typhus-associated gastrointestinal symptoms was not indicative of endoscopic findings, but…
Meeting News Coverage

Disinfectant use greatly reduced virus spread in facilities

September 10, 2014
Noroviruses capable of quickly contaminating facilities can be slowed effectively through the use of wipes containing quaternary ammonium compounds…
Meeting News Coverage

HBV, HIV seroprevalence high among pregnant women at Cameroon clinic

September 9, 2014
WASHINGTON, D.C. — Pregnant women in Cameroon had a high seroprevalence for hepatitis B virus infection and HIV, but not hepatitis C virus…
figure Meeting News Coverage

Performance, workflow similar between C. difficile QS-RGQ kit, Cepheid Xpert test

September 9, 2014
WASHINGTON, D.C. — The artus Clostridium difficile QS-RGQ Kit, an FDA-approved commercially available CE-Ivd from Qiagen, demonstrated similar…
figure In the Journals

HEV seroprevalence declined by 70% in US since 1994

September 9, 2014
The seroprevalence of hepatitis E virus infection in the US has decreased more than threefold since the 1990s, according to a study that examined…
figure Meeting News Coverage

Patient-reported outcome tool for C. difficile-associated diarrhea accurately addressed patient experience

September 9, 2014
WASHINGTON, D.C. — Patients reported that a new patient-reported outcome assessment tool developed based on the FDA PRO Guidance for Industry…
More Headlines »